Elicio Therapeutics, Inc. (ELTX)
1.68
-0.07
(-4.00%)
USD |
NASDAQ |
Oct 30, 16:00
1.695
+0.02
(+0.89%)
After-Hours: 20:00
Elicio Therapeutics Total Liabilities (Quarterly) : 23.39M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.39M |
| March 31, 2026 | 24.13M |
| December 31, 2025 | 24.23M |
| September 30, 2025 | 24.47M |
| June 30, 2025 | 27.69M |
| March 31, 2025 | 19.24M |
| December 31, 2024 | 39.49M |
| September 30, 2024 | 57.37M |
| June 30, 2024 | 17.40M |
| March 31, 2024 | 19.61M |
| December 31, 2023 | 15.77M |
| September 30, 2023 | 17.70M |
| June 30, 2023 | 14.06M |
| March 31, 2023 | 2.101M |
| Date | Value |
|---|---|
| December 31, 2022 | 13.75M |
| September 30, 2022 | 11.11M |
| June 30, 2022 | |
| March 31, 2022 | 14.06M |
| December 31, 2021 | 15.01M |
| September 30, 2021 | 45.43M |
| June 30, 2021 | 48.17M |
| March 31, 2021 | 46.76M |
| December 31, 2020 | 137.80M |
| September 30, 2020 | 85.94M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 30.47M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 46.42M |
| Armata Pharmaceuticals, Inc. | 321.12M |
| Voyager Therapeutics, Inc. | 43.38M |
| Black Diamond Therapeutics, Inc. | 28.94M |
| Invivyd, Inc. | 37.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.33M |
| Shareholders Equity (Quarterly) | 7.937M |
| Debt to Equity Ratio | 1.782 |
| Current Ratio | 2.770 |
| Net Debt Paydown Yield | -1.95% |